What the FDA and EMA's New AI Principles Mean for Pharmacovigilance
Discover the FDA and EMA's new AI principles for PV, emphasizing human oversight, risk management, and compliance in AI-driven safety workflows.
Is Your AI-Assisted PV Process Audit-Ready? Here's What Inspectors Ask
What inspectors actually ask about AI-assisted PV decisions — and how to document, govern, and defend them before they ask.
AESI Definitions Change Mid-Trial. Here's How to Handle It
Learn how to effectively manage AESI definition changes during trials to ensure compliance and defensibility, avoiding common pitfalls in case adjudication
